Market Tracker

06/21 5:15pm ET

Vanguard Health Care Index Fund ETF Shares (VHT)

162.64
Delayed Data
As of 4:10pm ET
 -1.15 / -0.70%
Today’s Change
144.38
Today|||52-Week Range
171.30
+5.51%
Year-to-Date

Investment Objective

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50- an index made up of stocks of large- mid-size- and small U.S. companies within the health care sector- as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all- or substantially all- of its assets in the stocks that make up the index- in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

No recent news for Vanguard Health Care Index Fund ETF Shares.

Performance

1 month+3.40% 3 years+6.34%
3 months+3.18% 5 years+15.51%
1 year+12.95% Since inception+9.96%
Data through 06/21/2018

Quote Details

Previous close$163.79
Open day’s range162.32 – 163.69
Net asset value (NAV)163.71 (06/20/2018)
Daily volume96,488
Average volume (3 months)146,465
Data as of 4:10pm ET, 06/21/2018

Peer Comparisonvs. Health ETFs

 VHTCategory
Performance 5-yr return+15.51%+14.29%
Expense Gross exp ratio0.10%1.29%
Risk 5 year sharpe ratio1.080.90
Net assets$8.3B$3.0B
Average market cap$51.7B$9.5B
Average P/E26.121.7
Dividend / Share--0.30%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Invesco S&P 500® Equal Weight Health Ca...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.05%
Hardware 1.62%
Business service 0.22%
Financial service 0.05%
Consumer service 0.02%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson8.38%
UNH UnitedHealth6.11%
PFE Pfizer5.59%
MRK Merck4.19%
ABBV AbbVie4.10%
AMGN Amgen3.16%
MDT Medtronic PLC3.06%
ABT Abbott Laboratories2.81%
GILD Gilead Sciences2.31%
BMY Bristol-Myers Squibb2.24%